The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
122463045 12246304 5 F 20160325 20160714 20160407 20160719 EXP US-JNJFOC-20160400662 JANSSEN 73.51 YR E F Y 63.50000 KG 20160719 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
122463045 12246304 1 PS TRABECTEDIN TRABECTEDIN 1 Intravenous (not otherwise specified) Y N 4369255-6190 207953 INTRAVENOUS INFUSION
122463045 12246304 2 SS TRABECTEDIN TRABECTEDIN 1 Intravenous (not otherwise specified) DAY 1, 1.1287 MG/M2 Y N 4369255-6190 114938 1.93 MG INTRAVENOUS INFUSION
122463045 12246304 3 SS DOXORUBICIN HYDROCHLORIDE. DOXORUBICIN HYDROCHLORIDE 1 Intravenous (not otherwise specified) Y N 4371305-27108 50718 LIPOSOME INJECTION
122463045 12246304 4 SS DOXORUBICIN HYDROCHLORIDE. DOXORUBICIN HYDROCHLORIDE 1 Intravenous (not otherwise specified) DAY 1, 30.7018 MG/M2 Y N 4371305-27108 36778 52.5 MG LIPOSOME INJECTION
122463045 12246304 5 C ASPRIN ASPIRIN 1 Oral 0 81 MG UNSPECIFIED
122463045 12246304 6 C VITAMIN B COMPLEX CYANOCOBALAMINDEXPANTHENOLNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVIN 5'-PHOSPHATE SODIUMTHIAMINE HYDROCHLORIDEVITAMIN B COMPLEX 1 Oral 0 1 DF TABLET
122463045 12246304 7 C CALCIUM 600 PLUS VITAMIN D CALCIUM CARBONATEVITAMIN D 1 Oral 0 1 DF TABLET
122463045 12246304 8 C CLARITIN LORATADINE 1 Oral 0 10 MG TABLET
122463045 12246304 9 C FERROUS SULFATE. FERROUS SULFATE 1 Oral 0 45 MG UNKNOWN
122463045 12246304 10 C FOLIC ACID. FOLIC ACID 1 Oral 0 1 MG UNSPECIFIED
122463045 12246304 11 C PRILOSEC OMEPRAZOLE MAGNESIUM 1 Oral 0 20 MG UNSPECIFIED
122463045 12246304 12 C SYNTHROID LEVOTHYROXINE SODIUM 1 Oral 0 125 UG UNSPECIFIED
122463045 12246304 13 C VITAMIN D3 CHOLECALCIFEROL 1 Oral DOSE: 2000 UNITS UNSPECIFIED 0 UNSPECIFIED
122463045 12246304 14 C MULTIVITAMINS VITAMINS 1 Oral 0 1 DF UNSPECIFIED
122463045 12246304 15 C COLACE DOCUSATE SODIUM 1 Oral 0 100 MG UNSPECIFIED
122463045 12246304 16 C DULCOLAX NOS BISACODYL OR DOCUSATE SODIUM 1 Oral 0 5 MG UNSPECIFIED
122463045 12246304 17 C MELATONIN MELATONIN 1 Oral 0 3 MG UNSPECIFIED
122463045 12246304 18 C BENADRYL DIPHENHYDRAMINE HYDROCHLORIDE 1 Oral 0 25 MG UNSPECIFIED
122463045 12246304 19 C TYLENOL ACETAMINOPHEN 1 Oral 0 1000 MG UNSPECIFIED

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
122463045 12246304 2 Ovarian cancer
122463045 12246304 4 Ovarian cancer
122463045 12246304 12 Hypothyroidism
122463045 12246304 15 Constipation
122463045 12246304 16 Constipation
122463045 12246304 17 Insomnia
122463045 12246304 18 Insomnia
122463045 12246304 19 Headache

Outcome of event

Event ID CASEID OUTC COD
122463045 12246304 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
122463045 12246304 Pyrexia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
122463045 12246304 2 20160121 20160303 0
122463045 12246304 4 20160121 20160303 0